Description
An immigrant's story of leadership, innovation, and humanity in cannabis medicine. Seeds of Hope is an eye-opening memoir of self-discovery and entrepreneurship set against a backdrop of the war on drugs. It's also a story of the transformative power of medical cannabis and its potential to revolutionize the healthcare industry. Written by Dr. Oludare Odumosu, MPH, PhD, it takes readers on a personal journey as he progresses from "just say no" to become one of the leading voices in the global cannabinoid space. Dr. Odumosu explores the history of cannabis and the devastating effects of the War on Drugs on cannabis medicine, addiction, and the minority community. He shares his personal experience in cannabis medicine and entrepreneurship, including fears, frustrations, and triumphs, as he and his team run an ever-changing gauntlet of state and federal rules and regulations. Seeds of Hope is a must-read for anyone interested in the transformative power of medical cannabis, including aspiring entrepreneurs. It's also an inspiring memoir that offers hope, insights, and lessons learned on leadership, success, and achieving one's dreams.
About the Author
Oludare ('Dare) Odumosu, MPH, PhD, is the CEO of Zelira Therapeutics, a global cannabinoid research and development company that made history with the world's first successful Phase 1/2a clinical trials for a cannabis-based insomnia medicine. Zelira has developed and commercialized cannabinoid formulations focused on insomnia, autism, chronic pain, Parkinson's, and more. At age 37, he became one of the youngest black CEOs of a publicly traded global cannabinoid biopharmaceutical company. Patrick F. O'Donnell is an author, ghostwriter, content writer, copy editor, and proofreader with more than 30 years of both journalism and marketing industry experience.
About the Author
Oludare ('Dare) Odumosu, MPH, PhD, is the CEO of Zelira Therapeutics, a global cannabinoid research and development company that made history with the world's first successful Phase 1/2a clinical trials for a cannabis-based insomnia medicine. Zelira has developed and commercialized cannabinoid formulations focused on insomnia, autism, chronic pain, Parkinson's, and more. At age 37, he became one of the youngest black CEOs of a publicly traded global cannabinoid biopharmaceutical company. Patrick F. O'Donnell is an author, ghostwriter, content writer, copy editor, and proofreader with more than 30 years of both journalism and marketing industry experience.
Wishlist
Wishlist is empty.
Compare
Shopping cart